top of page
About Us

Aging Analytics Agency is the world’s premier provider of industry analytics on the topics of Longevity, Precision Preventive Medicine and Economics of Aging, and the convergence of technologies such as AI, Blockchain, Digital Health and their impact on the healthcare industry.


The company provides strategic consulting services in fields relating to Longevity, and currently serves as the primary source of analytics and data for the UK All-Party Parliamentary Group for Longevity.


Aging Analytics Agency is the only analytics company focused exclusively on the topics of Aging, Geroscience and Longevity. Founded in 2013, with headquarters in London, UK and branches in Europe, US and Canada, it began producing in-depth reports on Longevity long before it emerged as an industry.

Screenshot 2020-02-11 at 17.44.12.png

In 2014, it successfully predicted the boom in industry development and financing rounds that occurred in 2017-2018, three years in advance, at a time when the vast majority of investors, business analysts, and even geroscientists believed its emergence to be in the next decade.


The company has also established reputation for developing sophisticated, highly multidimensional comparative analytics framework for the Longevity, Regenerative Medicine and Precision Preventive Medicine industries, as well as the rising sector of Longevity Financial Industry, allowing for practical and tangible forecasts to be applied to industries that are otherwise too complex for standard analytical approaches to be used in a relevant way. 


It has been developing enhanced iterations of its proprietary analytics system since 2015, and will serve as the main source for data for the soon-to-be-launched specialized Longevity index hedge fund Longevity.Capital, helping to establish pragmatic portfolio company valuation and efficient due-diligence procedures, and to structure advanced investment strategy in the overly-complex Longevity industry.


In 2019, Aging Analytics Agency significantly enhanced its executive management team with the addition of several prominent Longevity industry experts and specialists, including the appointment of Eric Kilhstrom as the new Director, former Interim Director of the UK Government-led £98 million Healthy Ageing Industrial Strategy Challenge Fund.


Aging Analytics Agency is a subsidiary of Deep Knowledge Group

Deep Knowledge Group is a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, media, philanthropy and more.

Aging Analytics Agency works closely with a consortium of non-profit and for-profit organizations including:

Deep Knowledge Analytics is a deep tech analytical agency using multidimensional algorithms to produce advanced industrial reports on DeepTech and frontier technologies. An online analytics platform with interactive visuals updated in real-time was released early this year.

The Pharma Division of Deep Knowledge Analytics specializes in the production of the most comprehensive analytical reports on the topics of Artificial Intelligence, Drug Discovery, Data Science, and Digital Health within the broader Pharma Healthcare Industry and intersection of AI and Pharma.

The GovTech Division of Deep Knowledge Analytics focuses on producing sophisticated openaccess and proprietary analytics the reveal factors driving the ongoing transformation of the global GovTech industry, main sectors to be changed, barriers to this process, and ways to overcome them.

NeuroTech Analytics specializes in the production of open-access and commercial comparative analytics on the full scope of the global NeuroTech industry, ranging from brain-computer interfaces to implant technologies, neurostimulation and neuromodulation, and neuroplasticity-increasing apps.

Biogerontology Research Foundation is a non-profit focused on Longevity , disease treatment and precision prevention. It is actively involved in UK Longevity Policy, Politics and government initiatives. Its aim is to neutralize the economic burden of an Ageing population.

Longevity Swiss Foundation Engaged with members of the Swiss government in establishing a National Swiss Longevity Development Plan to extend life expectancy through the application of AI, working alongside Swiss financial institutions, making Switzerland a leader in Longevity, Precision Health and Biomedicine.

The Longevity AI Consortium will serve as a leading R&D hub and industry-academic hotspot for advanced AI-driven personalized preventive diagnostics, prognostics and therapeutics. The main concept of precision medicine is providing health care which is individually tailored to a person’s genes, lifestyle and environment.

Longevity Media Company is a source of the latest Longevity news, from science to lifestyle and investment. We aim to expand through curating relevant news to the public and hosting conferences. We also offer partnership opportunities and consulting services tuned to the needs of investors and HNWIs.

Aging Analytics Agency works closely with Investment Funds including:

Deep Knowledge Group is a leading data-driven investment fund focused on the synergetic convergence of DeepTech, frontier technologies and technological megatrends, renowned for its use of sophisticated analytical system for investment target identification and due-diligence. While it’s major short-term interests are AI and DeepTech, it’s long term vision is focused on Longevity and Precision Health. The fund has offices in London, Zurich, Geneva, San Francisco, Toronto, Hawaii, Edinburgh, and Hong Kong.

Longevity.Capital is a hybrid investment fund specifically focused on the Longevity Industry, backed by seasoned professionals who have been active in both the investment banking and Longevity industries for 25+ years, long before the sector was recognized as a serious prospect by the overwhelming majority of investors. The fund structures its portfolio based on sophisticated industry intelligence and comparative analytics provided by the world-leading Longevity Analytics entity Aging Analytics Agency.

AI-Pharma.Capital is a hybrid investment fund focused on the AI in Pharma and Drug discovery sectors, backed by seasoned professionals who have been active in both the investment banking and AI for Drug Discovery industries for years, long before the sector was recognized as a serious prospect by the overwhelming majority of investors, and some of whom made their first investments into the sector in 2014. The Fund structures its portfolio based on industry intelligence and analytics by the Pharma Division of Deep Knowledge Analytics.

bottom of page